XML 50 R33.htm IDEA: XBRL DOCUMENT
v3.22.4

SHAREHOLDERS' EQUITY (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Schedule of stock option activity |
|  |  |  | Weighted average |  |  |  |
|  | Number of options and RSUs |  |  | Exercise price |  |  | Remaining contractual term (in years) |  |  | Aggregate intrinsic value |
Outstanding at January 1, 2022 |  |  | 3,574,401 |  |  | $ | 2.46 |  |  |  | 45.90 |  |  | $ | 77,173 |
Granted |  |  | 1,532,548 |  |  |  | 0.01 |  |  |  | - |  |  |  | - |
Exercised |  |  | (1,824,876 | ) |  |  | 2.19 |  |  |  | - |  |  |  | 35,811 |
Cancelled |  |  | (217,399 | ) |  |  | 2.53 |  |  |  | - |  |  |  | - |
Outstanding at December 31, 2022 |  |  | 3,064,674 |  |  | $ | 1.39 |  |  |  | 59.70 |  |  | $ | 73,284 |
Exercisable at December 31, 2022 |  |  | 618,230 |  |  | $ | 5.10 |  |  |  | 3.30 |  |  | $ | 12,488 |
Vested and expected to vest at December 31, 2022 |  |  | 3,264,763 |  |  | $ | 1.46 |  |  |  | 0.88 |  |  | $ | 138,673 |
Schedule of option activity by price range |
|  |  | Outstanding |  |  | Exercisable |
Range of exercise price |  |  | Number of options and RSUs |  |  | Weighted average remaining contractual life (years) |  |  | Weighted average exercise price |  |  | Number of options and RSUs |  |  | Weighted average remaining contractual life (years) |  |  | Weighted average exercise price |
$ | 0.01 |  |  |  | 2,323,813 |  |  |  | 77.65 |  |  | $ | 0.01 |  |  |  | - |  |  |  | - |  |  | $ | - |
| 2.52 – 3.38 |  |  |  | 237,699 |  |  |  | 2.39 |  |  |  | 3.19 |  |  |  | 237,699 |  |  |  | 2.39 |  |  |  | 3.19 |
| 4.23 – 5.90 |  |  |  | 258,475 |  |  |  | 3.97 |  |  |  | 5.21 |  |  |  | 244,412 |  |  |  | 3.93 |  |  |  | 5.18 |
| 6.23 – 8.34 |  |  |  | 180,932 |  |  |  | 3.18 |  |  |  | 6.73 |  |  |  | 105,834 |  |  |  | 3.32 |  |  |  | 6.80 |
$ | 12.02 – 21.35 |  |  |  | 63,755 |  |  |  | 5.19 |  |  |  | 14.60 |  |  |  | 30,285 |  |  |  | 5.15 |  |  |  | 13.50 |
|  |  |  |  | 3,064,674 |  |  |  | 59.70 |  |  | $ | 1.39 |  |  |  | 618,230 |  |  |  | 3.30 |  |  | $ | 5.10 |
Schedule of stock-based compensation expense |
|  | Year ended December 31, |
|  | 2022 |  |  | 2021 |  |  | 2020 |
Cost of revenue |  | $ | 446 |  |  | $ | 171 |  |  | $ | 102 |
Research and development |  |  | 2,129 |  |  |  | 946 |  |  |  | 887 |
Selling and marketing |  |  | 4,528 |  |  |  | 3,248 |  |  |  | 1,898 |
General and administrative |  |  | 4,467 |  |  |  | 2,620 |  |  |  | 1,560 |
Total |  | $ | 11,570 |  |  | $ | 6,985 |  |  | $ | 4,447 |
Performance Based Stock Options Member |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Schedule of stock option activity |
|  | Number of |  |  | Weighted average |  |  |  |
|  | Performance based options and RSUs |  |  | Exercise price |  |  | Remaining contractual term (in years) |  |  | Aggregate intrinsic value |
Outstanding at January 1, 2022 |  |  | 903,900 |  |  | $ | 2.37 |  |  |  | 46.16 |  |  | $ | 19,599 |
Granted |  |  | 417,628 |  |  |  | 0.01 |  |  |  | - |  |  |  | - |
Exercised |  |  | (650,794 | ) |  |  | 2.83 |  |  |  | - |  |  |  | 12,493 |
Cancelled |  |  | (78,223 | ) |  |  | 0.01 |  |  |  | - |  |  |  | - |
Outstanding at December 31, 2022 |  |  | 592,511 |  |  | $ | 0.51 |  |  |  | 70.64 |  |  | $ | 14,690 |
Exercisable at December 31, 2022 |  |  | 56,250 |  |  | $ | 5.35 |  |  |  | 4.58 |  |  | $ | 1,122 |
Vested and expected to vest at December 31, 2022 |  |  | 658,487 |  |  | $ | 0.46 |  |  |  | 0.39 |  |  | $ | 29,926 |
Schedule of option activity by price range |
|  |  | Outstanding |  |  | Exercisable |
Range of exercise price |  |  | Number of options and RSUs |  |  | Weighted average remaining contractual life (years) |  |  | Weighted average exercise price |  |  | Number of options and RSUs |  |  | Weighted average remaining contractual life (years) |  |  | Weighted average exercise price |
$ | 0.01 |  |  |  | 536,261 |  |  |  | 77.57 |  |  | $ | 0.01 |  |  |  | - |  |  |  | - |  |  | $ | - |
$ | 5.35 |  |  |  | 56,250 |  |  |  | 4.58 |  |  |  | 5.35 |  |  |  | 56,250 |  |  |  | 4.58 |  |  |  | 5.35 |
|  |  |  |  | 592,511 |  |  |  | 70.64 |  |  | $ | 0.51 |  |  |  | 56,250 |  |  |  | 4.58 |  |  | $ | 5.35 |

X
- Definition Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=peri_PerformanceBasedStockOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |